Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Current.
Press releases published on May 31, 2025

PFM CRYPTO Launches New 2-Day XRP Cloud Mining Contract in Response to The Surge in Demand from Short-Term Income Investors
Farington, England, May 31, 2025 (GLOBE NEWSWIRE) -- Against the backdrop of a significant increase in demand for short-term crypto investment, PFM CRYPTO, a global cryptocurrency cloud mining platform, today announced the launch of its first 2-day short- …

PFM CRYPTO lance un nouveau contrat d'extraction en nuage XRP de 2 jours pour répondre à la forte demande des investisseurs en quête de revenus à court terme.
Farington, Angleterre, 31 mai 2025 (GLOBE NEWSWIRE) -- Dans un contexte de forte hausse de la demande d'investissements en crypto monnaies à court terme, PFM CRYPTO, plateforme mondiale d'extraction de crypto monnaies en nuage, a annoncé aujourd'hui le …

AI Meets XRPL: Nimanode’s $NMA Presale Gains Momentum as AI Agents Set to Transform Web3 Automation
LEEDS, United Kingdom, May 31, 2025 (GLOBE NEWSWIRE) -- Nimanode, the trailblazing AI-powered platform built on the XRP Ledger, has officially launched its $NMA token presale, which started on May 22, 2025 and will remain live for a 30-day window. As XRP …

Robex annonce la finalisation de son introduction en bourse
QUÉBEC, 31 mai 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. (« Robex » ou la « Société ») (TSX-V : RBX), producteur et développeur aurifère ouest-africain, a le plaisir d’annoncer le succès de son introduction sur la bourse australienne (« ASX ») avec 38 …

PAIRMiner Makes Bitcoin Mining More Accessible Amid Market Surge
Image by PAIRMiner STUTTGART, Germany, May 31, 2025 (GLOBE NEWSWIRE) -- As Bitcoin prices rise past key resistance levels, investor interest in digital assets is once again on the upswing. PAIRMiner, a cloud-based cryptocurrency mining platform, is helping …

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …

National Vitiligo Bond Inc., Foundation and Community Partners Announce June 2025 Events to Celebrate Vitiligo Awareness
ATLANTA, GA, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- In honor of Vitiligo Awareness Month, the National Vitiligo Bond Inc Foundation (Vitiligo Bond) and its community partners are proud to announce a series of impactful events throughout June …

Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma
Phase III NAPOLI 3 trial is the largest and has the longest follow-up for an interventional study in metastatic pancreatic adenocarcinoma1 Post-hoc analysis of NAPOLI 3 study determined characteristics associated with long-term survival, with median …

Lancaster Resources Announces Closing Conditions Met for Lake Cargelligo Acquisition
VANCOUVER, British Columbia, May 30, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF0) (“Lancaster”), is pleased to announce it has received approval from the Canadian Securities Exchange to complete the acquisition of …